ATHIRA ATH-1017-AD-0202

Back to Drug Development Trials
Drug Development Trials

About the trial

A Randomized, Placebo-Controlled, Translational Study of ATH-1017 in Subjects With Mild to Moderate Alzheimer’s Disease.

View study